Update on the pathogenesis of vitiligo
AUTOR(ES)
Marchioro, Helena Zenedin; Castro, Caio César Silva de; Fava, Vinicius Medeiros; Sakiyama, Paula Hitomi; Dellatorre, Gerson; Miot, Hélio Amante
FONTE
Anais Brasileiros de Dermatologia
DATA DE PUBLICAÇÃO
2022
RESUMO
Abstract Vitiligo is a complex disease whose pathogenesis results from the interaction of genetic components, metabolic factors linked to cellular oxidative stress, melanocyte adhesion to the epithelium, and immunity (innate and adaptive), which culminate in aggression against melanocytes. In vitiligo, melanocytes are more sensitive to oxidative damage, leading to the increased expression of proinflammatory proteins such as HSP70. The lower expression of epithelial adhesion molecules, such as DDR1 and E-cadherin, facilitates damage to melanocytes and exposure of antigens that favor autoimmunity. Activation of the type 1-IFN pathway perpetuates the direct action of CD8+ cells against melanocytes, facilitated by regulatory T-cell dysfunction. The identification of several genes involved in these processes sets the stage for disease development and maintenance. However, the relationship of vitiligo with environmental factors, psychological stress, comorbidities, and the elements that define individual susceptibility to the disease are a challenge to the integration of theories related to its pathogenesis.
Documentos Relacionados
- Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
- An update of genetic basis of PCOS pathogenesis
- Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum,,
- UPDATE ON THE SCVMA
- Onset of vitiligo in a patient with acquired secondary hypogonadism under treatment with testosterone gel 2%: inside the pathogenesis,